Go Back To Menu
Close
- Mailing Form
-
Medical Report*
-
Go Back To Menu
Parotid gland cancer is a malignant glandular tumor, most common in middle-aged and elderly individuals, with a slightly higher incidence in men. Whether treatment is timely directly affects patient prognosis. Missing the best treatment window can lead to tumor spread, increasing treatment difficulty and risk. Combining multiple treatment methods to enhance efficacy has become a current medical focus.
Immune reconstruction cell therapy enhances the anti-tumor activity of the patient’s own immune cells, effectively identifying and clearing cancer cells.
① Activates T cells and natural killer cells, enhancing immune surveillance.
② Regulates the immune microenvironment, reducing tumor immune evasion.
③ Combined with traditional therapies, improves treatment tolerance and efficacy.
④ Reduces treatment-related side effects and promotes patient recovery.
In actual treatment, tumor patients undergoing surgery, radiotherapy, or chemotherapy often face immune dysfunction, increased infection risks, and slow recovery. To help patients better endure the treatment process, improve tolerance, and enhance quality of life, phased immune reconstruction programs must be scientifically designed for different cycles.
● Short-term plan: Rapidly enhance immunity through immune cell reinfusion to strengthen anti-tumor effects.
● Mid-term plan: Reduce side effects of conventional treatments, promote recovery, and ensure completion of standardized therapy.
● Long-term plan: Comprehensive improvement of immunity through immune cell reconstruction, gut immunity restoration, elemental immunity rebuilding, and immune nutrition support, thereby enhancing quality of life and prolonging survival.
1. Surgical Resection
Surgery is the core of traditional parotid gland cancer treatment, mainly by removing the tumor and involved tissues to relieve symptoms and prevent local recurrence. Depending on tumor size and location, the facial nerve may be preserved or resected, and postoperative adjuvant therapy often improves outcomes.
2. Radiotherapy
Radiotherapy is often used as adjuvant therapy after surgery or as the primary treatment for advanced patients unsuitable for surgery. It can effectively control local tumors and reduce recurrence risk. Modern radiotherapy techniques, such as intensity-modulated radiotherapy (IMRT), precisely target tumors while protecting surrounding normal tissues.
3. Chemotherapy
Chemotherapy is mainly applied in advanced or metastatic parotid gland cancer, often combined with radiotherapy. It works by inhibiting tumor cell proliferation and delaying disease progression, but side effects require careful management.
4. Minimally Invasive Treatment Methods
Minimally invasive treatments for parotid gland cancer include endoscope-assisted surgery and radiofrequency ablation. These approaches reduce surgical trauma and shorten recovery time, suitable for some early-stage and recurrent cases.
Parotid gland cancer presents high treatment complexity. Experts at United Life International Medical Center point out that combining immune reconstruction cell therapy with multiple treatment approaches offers the potential to enhance overall efficacy and improve patient quality of life. Early comprehensive intervention is especially important.
